from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary: WINDTREE THERAPEUTICS INC /DE/ quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
WINDTREE THERAPEUTICS INC /DE/ Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2024 was $39,637,000, a 75% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)

Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$39,637,000	-$119,289,000	-75%	31 Dec 2024	10-K	15 Apr 2025	2024	FY
Q4 2023	$158,926,000	-$26,665,000	-14%	31 Dec 2023	10-K	15 Apr 2025	2024	FY
Q4 2022	$185,591,000	-$2,314,000	-1.2%	31 Dec 2022	10-K	16 Apr 2024	2023	FY
Q4 2021	$187,905,000	+$4,112,000	+2.2%	31 Dec 2021	10-K	31 Mar 2023	2022	FY
Q4 2020	$183,793,000	+$2,814,000	+1.6%	31 Dec 2020	10-K	31 Mar 2022	2021	FY
Q4 2019	$180,979,000	+$4,220,000	+2.4%	31 Dec 2019	10-K	29 Mar 2021	2020	FY
Q4 2018	$176,759,000	+$8,496,000	+5%	31 Dec 2018	10-K	03 Apr 2020	2019	FY
Q4 2017	$168,263,000	-$66,562,000	-28%	31 Dec 2017	10-K/A	23 Apr 2019	2018	FY
Q4 2016	$234,825,000	+$16,622,000	+7.6%	31 Dec 2016	10-K	17 Apr 2018	2017	FY
Q4 2015	$218,203,000	+$26,560,000	+14%	31 Dec 2015	10-K	31 Mar 2017	2016	FY
Q4 2014	$191,643,000	+$16,385,000	+9.3%	31 Dec 2014	10-K	29 Mar 2016	2015	FY
Q4 2013	$175,258,000	+$14,736,000	+9.2%	31 Dec 2013	10-K	16 Mar 2015	2014	FY
Q4 2012	$160,522,000	+$13,477,000	+9.2%	31 Dec 2012	10-K	17 Mar 2014	2013	FY
Q4 2011	$147,045,000			31 Dec 2011	10-K	15 Mar 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.